IL6 and renal carcinoma: While the biological interpretation of increased neutrophil counts is not evident, Blay et al (1997) demonstrated that IL-6 associated neutrophilia in renal-cell carcinoma could be decreased via the suppression of IL-6 or IL-6-associated paraneoplastic inflammatory syndrome in renal carcinoma.